Akèy › Kansè (tout kalite) › Pennsylvania › York
Etid klinik pou Kansè (tout kalite) nan York, PA
8 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote York (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Prospective Study to Assess a Diagnostic Aid for Cancer
Ap rekriteEtid obsèvasyon
- Cancer Care Associates of York, York
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Ap rekriteEtid obsèvasyon
- Cancer Care Associates of York, York
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- WellSpan Health-York Cancer Center, York
- WellSpan Health-York Hospital, York
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Ap rekriteEtid obsèvasyon
- Cancer Care Association of York, York
WellSpan-THRIVE Cancer QOL Study
Ap rekriteEtid obsèvasyon
- WellSpan York Cancer Center, York
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Ap rekriteEtid obsèvasyon
- Cancer Care Associates of York, York
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Cancer Care Associates of York, York
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Ap rekriteEtid obsèvasyon
- Cancer Care Associates of York, York
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan York
- Kansè Poumon ki pa ti selil15 etid
- Kansè poumon8 etid
- Kansè nan tete8 etid
- Karsinòm selil skuamèz tèt ak kou7 etid
- Kansè ovè6 etid
- Kansè pwostat5 etid
- Maladi atè koronè5 etid
- Kansè kolorektal4 etid
- Kansè Endomèt4 etid
- Kansè tete negatif triple4 etid
- Kansè Ezofajyen4 etid
- Melanom3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.